628 related articles for article (PubMed ID: 35431513)
21. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S
J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiome composition and risk factors in a large cross-sectional IBS cohort.
Agnello M; Carroll LN; Imam N; Pino R; Palmer C; Varas I; Greene C; Hitschfeld M; Gupta S; Almonacid DE; Hoaglin MC
BMJ Open Gastroenterol; 2020; 7(1):e000345. PubMed ID: 32518661
[TBL] [Abstract][Full Text] [Related]
23. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
[TBL] [Abstract][Full Text] [Related]
24. The Role of Acupuncture on the Gut-Brain-Microbiota Axis in Irritable Bowel Syndrome.
Yaklai K; Pattanakuhar S; Chattipakorn N; Chattipakorn SC
Am J Chin Med; 2021; 49(2):285-314. PubMed ID: 33622207
[TBL] [Abstract][Full Text] [Related]
25. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
26. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions.
Hyland NP; Quigley EM; Brint E
World J Gastroenterol; 2014 Jul; 20(27):8859-66. PubMed ID: 25083059
[TBL] [Abstract][Full Text] [Related]
27. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.
Theodorou V; Ait Belgnaoui A; Agostini S; Eutamene H
Gut Microbes; 2014; 5(3):430-6. PubMed ID: 25184834
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
[TBL] [Abstract][Full Text] [Related]
29. Electroacupuncture Relieves Irritable Bowel Syndrome by Regulating IL-18 and Gut Microbial Dysbiosis in a Trinitrobenzene Sulfonic Acid-Induced Post-Inflammatory Animal Model.
Song YF; Pei LX; Chen L; Geng H; Yuan MQ; Xu WL; Wu J; Zhou JY; Sun JH
Am J Chin Med; 2020; 48(1):77-90. PubMed ID: 31918565
[TBL] [Abstract][Full Text] [Related]
30. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
[TBL] [Abstract][Full Text] [Related]
31. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome.
Chen M; Ruan G; Chen L; Ying S; Li G; Xu F; Xiao Z; Tian Y; Lv L; Ping Y; Cheng Y; Wei Y
Front Endocrinol (Lausanne); 2022; 13():817100. PubMed ID: 35250873
[TBL] [Abstract][Full Text] [Related]
32. Effect of altered gut microbiota on visceral hypersensitivity of postinfectious irritable bowel syndrome mice.
Cheng F; Fan Z; Lin C; Zhu Y; He H; Dai N; Du L
Eur J Gastroenterol Hepatol; 2022 Dec; 34(12):1220-1230. PubMed ID: 36165068
[TBL] [Abstract][Full Text] [Related]
33. The Intestinal Microbiota in the Irritable Bowel Syndrome.
Collins SM
Int Rev Neurobiol; 2016; 131():247-261. PubMed ID: 27793222
[TBL] [Abstract][Full Text] [Related]
34. Unraveling the ties between irritable bowel syndrome and intestinal microbiota.
Hong SN; Rhee PL
World J Gastroenterol; 2014 Mar; 20(10):2470-81. PubMed ID: 24627584
[TBL] [Abstract][Full Text] [Related]
35. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
Kim GH; Lee K; Shim JO
Microbiol Spectr; 2023 Feb; 11(1):e0212522. PubMed ID: 36652592
[TBL] [Abstract][Full Text] [Related]
36. Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.
Pearson JS; Whorwell PJ
Curr Opin Gastroenterol; 2017 Jan; 33(1):21-25. PubMed ID: 28134688
[TBL] [Abstract][Full Text] [Related]
37. Dysbiosis in Irritable Bowel Syndrome.
Abraham P; Pratap N
J Assoc Physicians India; 2023 Sep; 71(9):75-81. PubMed ID: 38700306
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.
Jin Y; Ren X; Li G; Li Y; Zhang L; Wang H; Qian W; Hou X
J Gastroenterol Hepatol; 2018 Feb; 33(2):443-452. PubMed ID: 28573746
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota and intestinal immunity-A crosstalk in irritable bowel syndrome.
Chen Y; Feng S; Li Y; Zhang C; Chao G; Zhang S
Immunology; 2024 May; 172(1):1-20. PubMed ID: 38174581
[TBL] [Abstract][Full Text] [Related]
40. Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain.
Aziz MNM; Kumar J; Muhammad Nawawi KN; Raja Ali RA; Mokhtar NM
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
